{"id":"NCT01976728","sponsor":"Ferring Pharmaceuticals","briefTitle":"LutrePulse Hypogonadotropic Hypogonadism","officialTitle":"A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered Via OmniPod Pump for Ovulation Induction in Female Subjects With Primary Amenorrhea With Hypogonadotropic Hypogonadism","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-04-01","primaryCompletion":"2018-02-23","completion":"2018-02-23","firstPosted":"2013-11-06","resultsPosted":"2021-03-03","lastUpdate":"2021-03-03"},"enrollment":39,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Primary Amenorrhea With Hypogonadotropic Hypogonadism"],"interventions":[{"type":"DRUG","name":"Gonadorelin acetate subcutaneous (SC) 10 μg/pulse as a fixed dose, administered via. OmniPod pump","otherNames":["LutrePulse"]},{"type":"DRUG","name":"Gonadorelin acetate SC 15 μg/pulse as a fixed dose, administered via. OmniPod pump","otherNames":["LutrePulse"]},{"type":"DRUG","name":"Gonadorelin acetate SC 20 μg/pulse as a fixed dose, administered via. OmniPod pump","otherNames":["LutrePulse"]},{"type":"DRUG","name":"Placebo (SC 10, 15, or 20 μg/pulse as a fixed dose, administered via. OmniPod pump)","otherNames":[]}],"arms":[{"label":"LutrePulse 10 µg/pulse","type":"EXPERIMENTAL"},{"label":"LutrePulse 15 µg/pulse","type":"EXPERIMENTAL"},{"label":"LutrePulse 20 µg/pulse","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To compare the ovulation rate in women with primary amenorrhea with hypogonadotropic hypogonadism following pulsatile gonadotropin-releasing hormone (GnRH) treatment using the OmniPod pump versus placebo","primaryOutcome":{"measure":"Ovulation Rate","timeFrame":"From treatment Day 1 up to 4 weeks after second positive β-hCG test, approximately 9 weeks","effectByArm":[{"arm":"LutrePulse 10 µg/Pulse","deltaMin":1,"sd":null},{"arm":"LutrePulse 15 µg/Pulse","deltaMin":4,"sd":null},{"arm":"LutrePulse 20 µg/Pulse","deltaMin":5,"sd":null},{"arm":"Lutrepulse 15 μg/Pulse and 20 μg/Pulse Pooled","deltaMin":9,"sd":null},{"arm":"Placebo","deltaMin":0,"sd":null}],"pValues":[{"comp":"OG003 vs OG004","p":"0.0120"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":13,"exclusionCount":13},"locations":{"siteCount":35,"countries":["United States","Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":10},"commonTop":["Breast tenderness","Hot flushes","Abdominal distesion","Nausea","Application site pain"]}}